Tech Company Financing Transactions
Tetrous Funding Round
Tetrous closed a Series A funding round on 3/10/2025. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/10/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to increase its market penetration, develop further clinical data showing the improvement in outcomes for patients, and expand surgical applications of its patented technology, including for hip, knee, ankle and elbow procedures with existing and new product offerings.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Los Angeles, CA Undisclosed
USA
Los Angeles, CA Undisclosed
USA
Phone
Website
Email Address
Overview
Tetrous, Inc. is a regenerative medicine company guided by a team of influential surgeons and regenerative medicine scientists, and led by experienced medical device executives. We utilize next generation advanced technologies for enthesis repair in sports medicine applications. The first offering in the EnFix family of products is EnFix RC� for rotator cuff repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradley Patt
Browse more venture capital transactions:
Prev: 3/7/2025: Ceramic venture capital transaction
Next: 3/10/2025: Ocean Ledger venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs